nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—CYP3A7—Vincristine—sarcoma	0.102	0.12	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.102	0.12	CbGbCtD
Alfentanil—CYP3A4—Thiotepa—sarcoma	0.101	0.119	CbGbCtD
Alfentanil—ABCB1—Dactinomycin—sarcoma	0.0808	0.0951	CbGbCtD
Alfentanil—CYP3A5—Vincristine—sarcoma	0.0765	0.09	CbGbCtD
Alfentanil—ABCB1—Mitoxantrone—sarcoma	0.0723	0.0851	CbGbCtD
Alfentanil—CYP3A5—Etoposide—sarcoma	0.0701	0.0824	CbGbCtD
Alfentanil—ABCB1—Vincristine—sarcoma	0.0498	0.0586	CbGbCtD
Alfentanil—ABCB1—Etoposide—sarcoma	0.0456	0.0537	CbGbCtD
Alfentanil—CYP3A4—Mitoxantrone—sarcoma	0.0433	0.051	CbGbCtD
Alfentanil—ABCB1—Doxorubicin—sarcoma	0.0311	0.0366	CbGbCtD
Alfentanil—CYP3A4—Vincristine—sarcoma	0.0298	0.0351	CbGbCtD
Alfentanil—CYP3A4—Etoposide—sarcoma	0.0273	0.0321	CbGbCtD
Alfentanil—CYP3A4—Doxorubicin—sarcoma	0.0186	0.0219	CbGbCtD
Alfentanil—Respiratory arrest—Thiotepa—sarcoma	0.00511	0.0341	CcSEcCtD
Alfentanil—Myoclonus—Vincristine—sarcoma	0.00331	0.0221	CcSEcCtD
Alfentanil—Injection site pain—Thiotepa—sarcoma	0.00275	0.0184	CcSEcCtD
Alfentanil—Laryngospasm—Etoposide—sarcoma	0.00216	0.0144	CcSEcCtD
Alfentanil—Apnoea—Etoposide—sarcoma	0.0019	0.0127	CcSEcCtD
Alfentanil—Cardiac arrest—Thiotepa—sarcoma	0.00155	0.0104	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00146	0.00972	CcSEcCtD
Alfentanil—Cardiac arrest—Vincristine—sarcoma	0.00138	0.00918	CcSEcCtD
Alfentanil—Dermatitis atopic—Epirubicin—sarcoma	0.00122	0.00816	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Etoposide—sarcoma	0.00121	0.00808	CcSEcCtD
Alfentanil—Epistaxis—Thiotepa—sarcoma	0.00119	0.00791	CcSEcCtD
Alfentanil—Dermatitis atopic—Doxorubicin—sarcoma	0.00113	0.00755	CcSEcCtD
Alfentanil—Cardiac arrest—Etoposide—sarcoma	0.00111	0.00744	CcSEcCtD
Alfentanil—Connective tissue disorder—Thiotepa—sarcoma	0.00111	0.0074	CcSEcCtD
Alfentanil—Injection site pain—Epirubicin—sarcoma	0.00111	0.0074	CcSEcCtD
Alfentanil—Drowsiness—Mitoxantrone—sarcoma	0.00109	0.00725	CcSEcCtD
Alfentanil—Eye disorder—Thiotepa—sarcoma	0.00105	0.00704	CcSEcCtD
Alfentanil—Cardiac disorder—Thiotepa—sarcoma	0.00105	0.00699	CcSEcCtD
Alfentanil—Injection site pain—Doxorubicin—sarcoma	0.00103	0.00685	CcSEcCtD
Alfentanil—Angiopathy—Thiotepa—sarcoma	0.00102	0.00683	CcSEcCtD
Alfentanil—Immune system disorder—Thiotepa—sarcoma	0.00102	0.0068	CcSEcCtD
Alfentanil—Mediastinal disorder—Thiotepa—sarcoma	0.00102	0.00679	CcSEcCtD
Alfentanil—Chills—Thiotepa—sarcoma	0.00101	0.00676	CcSEcCtD
Alfentanil—Arrhythmia—Thiotepa—sarcoma	0.00101	0.00673	CcSEcCtD
Alfentanil—Chills—Dactinomycin—sarcoma	0.00101	0.00671	CcSEcCtD
Alfentanil—Bronchospasm—Etoposide—sarcoma	0.000996	0.00665	CcSEcCtD
Alfentanil—Bradycardia—Mitoxantrone—sarcoma	0.000992	0.00662	CcSEcCtD
Alfentanil—Mental disorder—Thiotepa—sarcoma	0.000989	0.0066	CcSEcCtD
Alfentanil—Connective tissue disorder—Vincristine—sarcoma	0.000984	0.00656	CcSEcCtD
Alfentanil—Erythema—Thiotepa—sarcoma	0.000983	0.00656	CcSEcCtD
Alfentanil—Erythema—Dactinomycin—sarcoma	0.000975	0.00651	CcSEcCtD
Alfentanil—Dyskinesia—Epirubicin—sarcoma	0.000963	0.00643	CcSEcCtD
Alfentanil—Cardiac disorder—Vincristine—sarcoma	0.000929	0.0062	CcSEcCtD
Alfentanil—Vision blurred—Thiotepa—sarcoma	0.000926	0.00618	CcSEcCtD
Alfentanil—Angiopathy—Vincristine—sarcoma	0.000908	0.00606	CcSEcCtD
Alfentanil—Hiccups—Epirubicin—sarcoma	0.000905	0.00604	CcSEcCtD
Alfentanil—Agitation—Thiotepa—sarcoma	0.000903	0.00603	CcSEcCtD
Alfentanil—Mediastinal disorder—Vincristine—sarcoma	0.000902	0.00602	CcSEcCtD
Alfentanil—Dyskinesia—Doxorubicin—sarcoma	0.000891	0.00595	CcSEcCtD
Alfentanil—Mental disorder—Vincristine—sarcoma	0.000877	0.00585	CcSEcCtD
Alfentanil—Chills—Mitoxantrone—sarcoma	0.000875	0.00584	CcSEcCtD
Alfentanil—Arrhythmia—Mitoxantrone—sarcoma	0.000871	0.00581	CcSEcCtD
Alfentanil—Cough—Thiotepa—sarcoma	0.000857	0.00572	CcSEcCtD
Alfentanil—Convulsion—Thiotepa—sarcoma	0.000851	0.00568	CcSEcCtD
Alfentanil—Erythema—Mitoxantrone—sarcoma	0.000849	0.00566	CcSEcCtD
Alfentanil—Hypertension—Thiotepa—sarcoma	0.000848	0.00566	CcSEcCtD
Alfentanil—Hiccups—Doxorubicin—sarcoma	0.000837	0.00559	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000831	0.00554	CcSEcCtD
Alfentanil—Confusional state—Thiotepa—sarcoma	0.000809	0.0054	CcSEcCtD
Alfentanil—Agitation—Vincristine—sarcoma	0.000801	0.00534	CcSEcCtD
Alfentanil—Vision blurred—Mitoxantrone—sarcoma	0.0008	0.00534	CcSEcCtD
Alfentanil—Nervous system disorder—Thiotepa—sarcoma	0.000786	0.00525	CcSEcCtD
Alfentanil—Tachycardia—Thiotepa—sarcoma	0.000783	0.00522	CcSEcCtD
Alfentanil—Skin disorder—Thiotepa—sarcoma	0.000779	0.0052	CcSEcCtD
Alfentanil—Eye disorder—Etoposide—sarcoma	0.000758	0.00506	CcSEcCtD
Alfentanil—Convulsion—Vincristine—sarcoma	0.000755	0.00504	CcSEcCtD
Alfentanil—Cardiac disorder—Etoposide—sarcoma	0.000753	0.00502	CcSEcCtD
Alfentanil—Hypertension—Vincristine—sarcoma	0.000752	0.00502	CcSEcCtD
Alfentanil—Cough—Mitoxantrone—sarcoma	0.00074	0.00494	CcSEcCtD
Alfentanil—Angiopathy—Etoposide—sarcoma	0.000736	0.00491	CcSEcCtD
Alfentanil—Convulsion—Mitoxantrone—sarcoma	0.000735	0.00491	CcSEcCtD
Alfentanil—Hypertension—Mitoxantrone—sarcoma	0.000733	0.00489	CcSEcCtD
Alfentanil—Immune system disorder—Etoposide—sarcoma	0.000732	0.00489	CcSEcCtD
Alfentanil—Mediastinal disorder—Etoposide—sarcoma	0.000731	0.00488	CcSEcCtD
Alfentanil—Chills—Etoposide—sarcoma	0.000728	0.00486	CcSEcCtD
Alfentanil—Somnolence—Thiotepa—sarcoma	0.000713	0.00476	CcSEcCtD
Alfentanil—Anaphylactic shock—Vincristine—sarcoma	0.000711	0.00475	CcSEcCtD
Alfentanil—Confusional state—Mitoxantrone—sarcoma	0.000698	0.00466	CcSEcCtD
Alfentanil—Nervous system disorder—Vincristine—sarcoma	0.000697	0.00465	CcSEcCtD
Alfentanil—Anaphylactic shock—Mitoxantrone—sarcoma	0.000693	0.00462	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Thiotepa—sarcoma	0.000692	0.00462	CcSEcCtD
Alfentanil—Fatigue—Thiotepa—sarcoma	0.000691	0.00461	CcSEcCtD
Alfentanil—Hyperhidrosis—Vincristine—sarcoma	0.000687	0.00459	CcSEcCtD
Alfentanil—Fatigue—Dactinomycin—sarcoma	0.000686	0.00458	CcSEcCtD
Alfentanil—Pain—Thiotepa—sarcoma	0.000686	0.00458	CcSEcCtD
Alfentanil—Pain—Dactinomycin—sarcoma	0.000681	0.00454	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Epirubicin—sarcoma	0.000679	0.00453	CcSEcCtD
Alfentanil—Tachycardia—Mitoxantrone—sarcoma	0.000676	0.00451	CcSEcCtD
Alfentanil—Skin disorder—Mitoxantrone—sarcoma	0.000673	0.00449	CcSEcCtD
Alfentanil—Hyperhidrosis—Mitoxantrone—sarcoma	0.00067	0.00447	CcSEcCtD
Alfentanil—Hypotension—Vincristine—sarcoma	0.000664	0.00443	CcSEcCtD
Alfentanil—Feeling abnormal—Thiotepa—sarcoma	0.000661	0.00441	CcSEcCtD
Alfentanil—Feeling abnormal—Dactinomycin—sarcoma	0.000656	0.00438	CcSEcCtD
Alfentanil—Hypotension—Mitoxantrone—sarcoma	0.000647	0.00432	CcSEcCtD
Alfentanil—Urticaria—Thiotepa—sarcoma	0.000637	0.00425	CcSEcCtD
Alfentanil—Body temperature increased—Thiotepa—sarcoma	0.000634	0.00423	CcSEcCtD
Alfentanil—Body temperature increased—Dactinomycin—sarcoma	0.000629	0.0042	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000628	0.00419	CcSEcCtD
Alfentanil—Cardiac arrest—Epirubicin—sarcoma	0.000625	0.00417	CcSEcCtD
Alfentanil—Loss of consciousness—Etoposide—sarcoma	0.00062	0.00414	CcSEcCtD
Alfentanil—Cough—Etoposide—sarcoma	0.000616	0.00411	CcSEcCtD
Alfentanil—Somnolence—Mitoxantrone—sarcoma	0.000616	0.00411	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Vincristine—sarcoma	0.000614	0.0041	CcSEcCtD
Alfentanil—Fatigue—Vincristine—sarcoma	0.000613	0.00409	CcSEcCtD
Alfentanil—Convulsion—Etoposide—sarcoma	0.000612	0.00408	CcSEcCtD
Alfentanil—Hypertension—Etoposide—sarcoma	0.000609	0.00407	CcSEcCtD
Alfentanil—Pain—Vincristine—sarcoma	0.000608	0.00406	CcSEcCtD
Alfentanil—Fatigue—Mitoxantrone—sarcoma	0.000597	0.00398	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000597	0.00398	CcSEcCtD
Alfentanil—Pain—Mitoxantrone—sarcoma	0.000592	0.00395	CcSEcCtD
Alfentanil—Hypersensitivity—Thiotepa—sarcoma	0.000591	0.00394	CcSEcCtD
Alfentanil—Hypersensitivity—Dactinomycin—sarcoma	0.000586	0.00391	CcSEcCtD
Alfentanil—Confusional state—Etoposide—sarcoma	0.000581	0.00388	CcSEcCtD
Alfentanil—Cardiac arrest—Doxorubicin—sarcoma	0.000578	0.00386	CcSEcCtD
Alfentanil—Anaphylactic shock—Etoposide—sarcoma	0.000576	0.00384	CcSEcCtD
Alfentanil—Asthenia—Thiotepa—sarcoma	0.000575	0.00384	CcSEcCtD
Alfentanil—Asthenia—Dactinomycin—sarcoma	0.000571	0.00381	CcSEcCtD
Alfentanil—Feeling abnormal—Mitoxantrone—sarcoma	0.000571	0.00381	CcSEcCtD
Alfentanil—Pruritus—Thiotepa—sarcoma	0.000567	0.00379	CcSEcCtD
Alfentanil—Tachycardia—Etoposide—sarcoma	0.000562	0.00375	CcSEcCtD
Alfentanil—Body temperature increased—Vincristine—sarcoma	0.000562	0.00375	CcSEcCtD
Alfentanil—Skin disorder—Etoposide—sarcoma	0.00056	0.00373	CcSEcCtD
Alfentanil—Hyperhidrosis—Etoposide—sarcoma	0.000557	0.00372	CcSEcCtD
Alfentanil—Urticaria—Mitoxantrone—sarcoma	0.00055	0.00367	CcSEcCtD
Alfentanil—Body temperature increased—Mitoxantrone—sarcoma	0.000547	0.00365	CcSEcCtD
Alfentanil—Hypotension—Etoposide—sarcoma	0.000538	0.00359	CcSEcCtD
Alfentanil—Dizziness—Thiotepa—sarcoma	0.00053	0.00354	CcSEcCtD
Alfentanil—Hypersensitivity—Vincristine—sarcoma	0.000524	0.0035	CcSEcCtD
Alfentanil—Somnolence—Etoposide—sarcoma	0.000512	0.00342	CcSEcCtD
Alfentanil—Hypersensitivity—Mitoxantrone—sarcoma	0.00051	0.00341	CcSEcCtD
Alfentanil—Asthenia—Vincristine—sarcoma	0.00051	0.0034	CcSEcCtD
Alfentanil—Vomiting—Thiotepa—sarcoma	0.00051	0.0034	CcSEcCtD
Alfentanil—Drowsiness—Epirubicin—sarcoma	0.000506	0.00338	CcSEcCtD
Alfentanil—Vomiting—Dactinomycin—sarcoma	0.000506	0.00338	CcSEcCtD
Alfentanil—Rash—Thiotepa—sarcoma	0.000506	0.00337	CcSEcCtD
Alfentanil—Dermatitis—Thiotepa—sarcoma	0.000505	0.00337	CcSEcCtD
Alfentanil—Headache—Thiotepa—sarcoma	0.000502	0.00335	CcSEcCtD
Alfentanil—Rash—Dactinomycin—sarcoma	0.000502	0.00335	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Etoposide—sarcoma	0.000497	0.00332	CcSEcCtD
Alfentanil—Asthenia—Mitoxantrone—sarcoma	0.000497	0.00332	CcSEcCtD
Alfentanil—Fatigue—Etoposide—sarcoma	0.000497	0.00331	CcSEcCtD
Alfentanil—Pain—Etoposide—sarcoma	0.000493	0.00329	CcSEcCtD
Alfentanil—Epistaxis—Epirubicin—sarcoma	0.000478	0.00319	CcSEcCtD
Alfentanil—Nausea—Thiotepa—sarcoma	0.000476	0.00318	CcSEcCtD
Alfentanil—Feeling abnormal—Etoposide—sarcoma	0.000475	0.00317	CcSEcCtD
Alfentanil—Nausea—Dactinomycin—sarcoma	0.000473	0.00316	CcSEcCtD
Alfentanil—Dizziness—Vincristine—sarcoma	0.00047	0.00314	CcSEcCtD
Alfentanil—Drowsiness—Doxorubicin—sarcoma	0.000468	0.00313	CcSEcCtD
Alfentanil—Bradycardia—Epirubicin—sarcoma	0.000463	0.00309	CcSEcCtD
Alfentanil—Urticaria—Etoposide—sarcoma	0.000458	0.00305	CcSEcCtD
Alfentanil—Body temperature increased—Etoposide—sarcoma	0.000455	0.00304	CcSEcCtD
Alfentanil—Vomiting—Vincristine—sarcoma	0.000452	0.00302	CcSEcCtD
Alfentanil—Rash—Vincristine—sarcoma	0.000448	0.00299	CcSEcCtD
Alfentanil—Dermatitis—Vincristine—sarcoma	0.000448	0.00299	CcSEcCtD
Alfentanil—Connective tissue disorder—Epirubicin—sarcoma	0.000447	0.00298	CcSEcCtD
Alfentanil—Headache—Vincristine—sarcoma	0.000445	0.00297	CcSEcCtD
Alfentanil—Epistaxis—Doxorubicin—sarcoma	0.000442	0.00295	CcSEcCtD
Alfentanil—Vomiting—Mitoxantrone—sarcoma	0.00044	0.00294	CcSEcCtD
Alfentanil—Visual impairment—Epirubicin—sarcoma	0.000438	0.00292	CcSEcCtD
Alfentanil—Rash—Mitoxantrone—sarcoma	0.000437	0.00291	CcSEcCtD
Alfentanil—Dermatitis—Mitoxantrone—sarcoma	0.000436	0.00291	CcSEcCtD
Alfentanil—Headache—Mitoxantrone—sarcoma	0.000434	0.0029	CcSEcCtD
Alfentanil—Bradycardia—Doxorubicin—sarcoma	0.000428	0.00286	CcSEcCtD
Alfentanil—Eye disorder—Epirubicin—sarcoma	0.000425	0.00283	CcSEcCtD
Alfentanil—Hypersensitivity—Etoposide—sarcoma	0.000424	0.00283	CcSEcCtD
Alfentanil—Nausea—Vincristine—sarcoma	0.000422	0.00282	CcSEcCtD
Alfentanil—Cardiac disorder—Epirubicin—sarcoma	0.000422	0.00281	CcSEcCtD
Alfentanil—Asthenia—Etoposide—sarcoma	0.000413	0.00276	CcSEcCtD
Alfentanil—Connective tissue disorder—Doxorubicin—sarcoma	0.000413	0.00276	CcSEcCtD
Alfentanil—Angiopathy—Epirubicin—sarcoma	0.000412	0.00275	CcSEcCtD
Alfentanil—Nausea—Mitoxantrone—sarcoma	0.000411	0.00275	CcSEcCtD
Alfentanil—Immune system disorder—Epirubicin—sarcoma	0.000411	0.00274	CcSEcCtD
Alfentanil—Mediastinal disorder—Epirubicin—sarcoma	0.00041	0.00273	CcSEcCtD
Alfentanil—Chills—Epirubicin—sarcoma	0.000408	0.00272	CcSEcCtD
Alfentanil—Pruritus—Etoposide—sarcoma	0.000408	0.00272	CcSEcCtD
Alfentanil—Arrhythmia—Epirubicin—sarcoma	0.000406	0.00271	CcSEcCtD
Alfentanil—Visual impairment—Doxorubicin—sarcoma	0.000405	0.0027	CcSEcCtD
Alfentanil—Mental disorder—Epirubicin—sarcoma	0.000398	0.00266	CcSEcCtD
Alfentanil—Erythema—Epirubicin—sarcoma	0.000396	0.00264	CcSEcCtD
Alfentanil—Eye disorder—Doxorubicin—sarcoma	0.000393	0.00262	CcSEcCtD
Alfentanil—Cardiac disorder—Doxorubicin—sarcoma	0.00039	0.0026	CcSEcCtD
Alfentanil—Angiopathy—Doxorubicin—sarcoma	0.000382	0.00255	CcSEcCtD
Alfentanil—Dizziness—Etoposide—sarcoma	0.000381	0.00254	CcSEcCtD
Alfentanil—Immune system disorder—Doxorubicin—sarcoma	0.00038	0.00253	CcSEcCtD
Alfentanil—Mediastinal disorder—Doxorubicin—sarcoma	0.000379	0.00253	CcSEcCtD
Alfentanil—Chills—Doxorubicin—sarcoma	0.000377	0.00252	CcSEcCtD
Alfentanil—Arrhythmia—Doxorubicin—sarcoma	0.000376	0.00251	CcSEcCtD
Alfentanil—Vision blurred—Epirubicin—sarcoma	0.000373	0.00249	CcSEcCtD
Alfentanil—Mental disorder—Doxorubicin—sarcoma	0.000368	0.00246	CcSEcCtD
Alfentanil—Vomiting—Etoposide—sarcoma	0.000366	0.00244	CcSEcCtD
Alfentanil—Erythema—Doxorubicin—sarcoma	0.000366	0.00244	CcSEcCtD
Alfentanil—Agitation—Epirubicin—sarcoma	0.000364	0.00243	CcSEcCtD
Alfentanil—Rash—Etoposide—sarcoma	0.000363	0.00242	CcSEcCtD
Alfentanil—Dermatitis—Etoposide—sarcoma	0.000363	0.00242	CcSEcCtD
Alfentanil—Headache—Etoposide—sarcoma	0.000361	0.00241	CcSEcCtD
Alfentanil—Loss of consciousness—Epirubicin—sarcoma	0.000348	0.00232	CcSEcCtD
Alfentanil—Cough—Epirubicin—sarcoma	0.000345	0.0023	CcSEcCtD
Alfentanil—Vision blurred—Doxorubicin—sarcoma	0.000345	0.0023	CcSEcCtD
Alfentanil—Convulsion—Epirubicin—sarcoma	0.000343	0.00229	CcSEcCtD
Alfentanil—Nausea—Etoposide—sarcoma	0.000342	0.00228	CcSEcCtD
Alfentanil—Hypertension—Epirubicin—sarcoma	0.000342	0.00228	CcSEcCtD
Alfentanil—Agitation—Doxorubicin—sarcoma	0.000336	0.00225	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000335	0.00223	CcSEcCtD
Alfentanil—Confusional state—Epirubicin—sarcoma	0.000326	0.00217	CcSEcCtD
Alfentanil—Anaphylactic shock—Epirubicin—sarcoma	0.000323	0.00215	CcSEcCtD
Alfentanil—Loss of consciousness—Doxorubicin—sarcoma	0.000322	0.00215	CcSEcCtD
Alfentanil—Cough—Doxorubicin—sarcoma	0.000319	0.00213	CcSEcCtD
Alfentanil—Convulsion—Doxorubicin—sarcoma	0.000317	0.00212	CcSEcCtD
Alfentanil—Nervous system disorder—Epirubicin—sarcoma	0.000317	0.00211	CcSEcCtD
Alfentanil—Hypertension—Doxorubicin—sarcoma	0.000316	0.00211	CcSEcCtD
Alfentanil—Tachycardia—Epirubicin—sarcoma	0.000315	0.0021	CcSEcCtD
Alfentanil—Skin disorder—Epirubicin—sarcoma	0.000314	0.00209	CcSEcCtD
Alfentanil—Hyperhidrosis—Epirubicin—sarcoma	0.000312	0.00208	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00031	0.00207	CcSEcCtD
Alfentanil—Hypotension—Epirubicin—sarcoma	0.000302	0.00201	CcSEcCtD
Alfentanil—Confusional state—Doxorubicin—sarcoma	0.000301	0.00201	CcSEcCtD
Alfentanil—Anaphylactic shock—Doxorubicin—sarcoma	0.000299	0.00199	CcSEcCtD
Alfentanil—Nervous system disorder—Doxorubicin—sarcoma	0.000293	0.00196	CcSEcCtD
Alfentanil—Tachycardia—Doxorubicin—sarcoma	0.000292	0.00195	CcSEcCtD
Alfentanil—Skin disorder—Doxorubicin—sarcoma	0.00029	0.00194	CcSEcCtD
Alfentanil—Hyperhidrosis—Doxorubicin—sarcoma	0.000289	0.00193	CcSEcCtD
Alfentanil—Somnolence—Epirubicin—sarcoma	0.000287	0.00192	CcSEcCtD
Alfentanil—Hypotension—Doxorubicin—sarcoma	0.000279	0.00186	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Epirubicin—sarcoma	0.000279	0.00186	CcSEcCtD
Alfentanil—Fatigue—Epirubicin—sarcoma	0.000278	0.00186	CcSEcCtD
Alfentanil—Pain—Epirubicin—sarcoma	0.000276	0.00184	CcSEcCtD
Alfentanil—Feeling abnormal—Epirubicin—sarcoma	0.000266	0.00178	CcSEcCtD
Alfentanil—Somnolence—Doxorubicin—sarcoma	0.000266	0.00177	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000258	0.00172	CcSEcCtD
Alfentanil—Fatigue—Doxorubicin—sarcoma	0.000258	0.00172	CcSEcCtD
Alfentanil—Urticaria—Epirubicin—sarcoma	0.000257	0.00171	CcSEcCtD
Alfentanil—Pain—Doxorubicin—sarcoma	0.000256	0.00171	CcSEcCtD
Alfentanil—Body temperature increased—Epirubicin—sarcoma	0.000255	0.0017	CcSEcCtD
Alfentanil—Feeling abnormal—Doxorubicin—sarcoma	0.000246	0.00164	CcSEcCtD
Alfentanil—Hypersensitivity—Epirubicin—sarcoma	0.000238	0.00159	CcSEcCtD
Alfentanil—Urticaria—Doxorubicin—sarcoma	0.000237	0.00158	CcSEcCtD
Alfentanil—Body temperature increased—Doxorubicin—sarcoma	0.000236	0.00158	CcSEcCtD
Alfentanil—Asthenia—Epirubicin—sarcoma	0.000232	0.00155	CcSEcCtD
Alfentanil—Pruritus—Epirubicin—sarcoma	0.000228	0.00152	CcSEcCtD
Alfentanil—Hypersensitivity—Doxorubicin—sarcoma	0.00022	0.00147	CcSEcCtD
Alfentanil—Asthenia—Doxorubicin—sarcoma	0.000214	0.00143	CcSEcCtD
Alfentanil—Dizziness—Epirubicin—sarcoma	0.000214	0.00142	CcSEcCtD
Alfentanil—Pruritus—Doxorubicin—sarcoma	0.000211	0.00141	CcSEcCtD
Alfentanil—Vomiting—Epirubicin—sarcoma	0.000205	0.00137	CcSEcCtD
Alfentanil—Rash—Epirubicin—sarcoma	0.000204	0.00136	CcSEcCtD
Alfentanil—Dermatitis—Epirubicin—sarcoma	0.000203	0.00136	CcSEcCtD
Alfentanil—Headache—Epirubicin—sarcoma	0.000202	0.00135	CcSEcCtD
Alfentanil—Dizziness—Doxorubicin—sarcoma	0.000198	0.00132	CcSEcCtD
Alfentanil—Nausea—Epirubicin—sarcoma	0.000192	0.00128	CcSEcCtD
Alfentanil—Vomiting—Doxorubicin—sarcoma	0.00019	0.00127	CcSEcCtD
Alfentanil—Rash—Doxorubicin—sarcoma	0.000188	0.00126	CcSEcCtD
Alfentanil—Dermatitis—Doxorubicin—sarcoma	0.000188	0.00126	CcSEcCtD
Alfentanil—Headache—Doxorubicin—sarcoma	0.000187	0.00125	CcSEcCtD
Alfentanil—Nausea—Doxorubicin—sarcoma	0.000177	0.00118	CcSEcCtD
